Search

Author/Creator Starr, Kate

1. Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. (9th July 2020)

Authors:
Smeaton, Laura M; Kileel, Emma M; Grinsztejn, Beatriz; Gardner, Edward M; Starr, Kate; Murry, Melissa L; Desvigne-Nickens, Patrice; Alston-Smith, Beverly; Waclawiw, Myron A; Cooper-Arnold, Katharine; Madruga, José V; Sangle, Shashi; Fitch, Kathleen V; Zanni, Markella V; Douglas, Pamela S; Ribaudo...
Journal:
Journal of infectious diseases
Issue:
Volume 222(2020)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial . (17th February 2022)

Authors:
Scully, Eileen P; Aga, Evgenia; Tsibris, Athe; Archin, Nancie; Starr, Kate; Ma, Qing; Morse, Gene D; Squires, Kathleen E; Howell, Bonnie J; Wu, Guoxin; Hosey, Lara; Sieg, Scott F; Ehui, Lynsay; Giguel, Francoise; Coxen, Kendyll; Dobrowolski, Curtis; Gandhi, Monica; Deeks, Steve; Chomont, Nicolas;...
Journal:
Clinical infectious diseases
Issue:
Volume 75:Number 8(2022)
Page Start:
1389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗